Posted By IMARC Services Private Limited
Posted on September 21, 2021
According to IMARC Group’s latest report, titled “H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. H1N1 refers to a subtype of the Influenza A virus that causes an infectious disease characterized by a persistent cough, high fever, red and watery eyes, body ache, headache, etc. It is known to have a detrimental effect on various existing chronic ailments, including pneumonia, Chronic Obstructive Pulmonary Disease (COPD), bronchitis, etc. H1N1 vaccines are a preventive measure taken through intradermal and intranasal procedures to offer active immunization against the virus.
Request for a PDF sample of this report: https://www.imarcgroup.com/h1n1-vaccines-market/requestsample
The rising incidences of H1N1 infection and the declining immunity of the general population against the virus are primarily driving the H1N1 vaccines market. Besides this, the expanding geriatric population across the globe is also bolstering the market growth since, with age, the risk of developing respiratory tract diseases and immunodeficiency disorders rises, making individuals more susceptible to the H1N1 virus. Additionally, the elevating levels of R&D activities in the field of immunology and vaccine technologies are also augmenting the global market. Apart from this, numerous developed countries, such as Australia and the United States, are adding H1N1 vaccines under their National Immunization Program (NIP), which is further propelling the product demand. Moreover, continuous technological advancements, coupled with the increasing awareness towards preventive methods, are expected to fuel the H1N1 vaccines market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Segmentation:
Breakup by Vaccine Type
- Intramuscular
- Intranasal
- Intradermal
Breakup by Market Type:
- Public
- Private
Analysis of Key Brands:
- Agripal
- Fiuarix
- Influgen
- Influvac
- Nasovac
- Vaxigrip
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/h1n1-vaccines-market
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
East Africa Generic Drug Market
India Minimally Invasive Surgery Market Size
Europe Transfection Technologies Market
Vein Illumination Devices Market
Nitinol Medical Devices Market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to IMARC Group’s latest report, titled “H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. H1N1 refers to a subtype of the Influenza A virus that causes an infectious disease characterized by a persistent cough, high fever, red and watery eyes, body ache, headache, etc. It is known to have a detrimental effect on various existing chronic ailments, including pneumonia, Chronic Obstructive Pulmonary Disease (COPD), bronchitis, etc. H1N1 vaccines are a preventive measure taken through intradermal and intranasal procedures to offer active immunization against the virus.
Request for a PDF sample of this report: https://www.imarcgroup.com/h1n1-vaccines-market/requestsample
The rising incidences of H1N1 infection and the declining immunity of the general population against the virus are primarily driving the H1N1 vaccines market. Besides this, the expanding geriatric population across the globe is also bolstering the market growth since, with age, the risk of developing respiratory tract diseases and immunodeficiency disorders rises, making individuals more susceptible to the H1N1 virus. Additionally, the elevating levels of R&D activities in the field of immunology and vaccine technologies are also augmenting the global market. Apart from this, numerous developed countries, such as Australia and the United States, are adding H1N1 vaccines under their National Immunization Program (NIP), which is further propelling the product demand. Moreover, continuous technological advancements, coupled with the increasing awareness towards preventive methods, are expected to fuel the H1N1 vaccines market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Segmentation:
Breakup by Vaccine Type
- Intramuscular
- Intranasal
- Intradermal
Breakup by Market Type:
- Public
- Private
Analysis of Key Brands:
- Agripal
- Fiuarix
- Influgen
- Influvac
- Nasovac
- Vaxigrip
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/h1n1-vaccines-market
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
East Africa Generic Drug Market
India Minimally Invasive Surgery Market Size
Europe Transfection Technologies Market
Vein Illumination Devices Market
Nitinol Medical Devices Market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
